Dyslipidemia Drugs Market Growth Accelerates Amid Rising Cardiovascular Disease Burden and Expanding Therapeutic Innovations
https://growthmarketreports.co....m/report/dyslipidaem
The global Dyslipidemia Drugs Market refers to the pharmaceutical industry focused on medications used to treat abnormal lipid levels in the blood, including elevated cholesterol and triglycerides. Dyslipidemia is a major risk factor for cardiovascular diseases, making this market a critical segment of global healthcare and preventive medicine.